PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12820742-11	2003	The MTP immunoassay resulted in specificities of 52% (methadone) to 95% (opiates, cocain, and metabolite) and sensitivities of 92% (amphetamines) up to 100% (methadone).	Methadone	54-63	metallothionein 1B	Homo sapiens	4-7	
22263715-5	2012	Patients who reached a moderate-to-high methadone dose demonstrated higher rates of reporting to community MTP versus lower doses, both pre- and post-QI.	Methadone	40-49	metallothionein 1B	Homo sapiens	107-110	
12820742-11	2003	The MTP immunoassay resulted in specificities of 52% (methadone) to 95% (opiates, cocain, and metabolite) and sensitivities of 92% (amphetamines) up to 100% (methadone).	Methadone	158-167	metallothionein 1B	Homo sapiens	4-7	
11263518-1	2001	SETTING: An out-patient methadone treatment program MTP).	Methadone	24-33	metallothionein 1B	Homo sapiens	52-55